Asthmatics unlikely to have severe COVID-19, show early US data

Asthmatics unlikely to have severe COVID-19, show early US data

Aren’t asthmatics at a higher risk for the severe form of COVID-19? If the data from preliminary research conducted in New York is anything to go by the answer appears negative.

Asthma as a comorbid condition figured nowhere on the list ten top diseases the contributed to the disease severity and death of the people who suffered COVID-19 infection, according to the initial data released this month from New York, the epicentre of COVID-19 outbreak in the US.

Similarly, a group of European researchers also noted a recent commentary published in The Lancet asthma appeared “to be underrepresented” in the comorbidities reported for patients with COVID-19.

The top comorbidities listed among the New Yorkers who died of COVID-19-related ailments were hypertension, diabetes, high cholesterol, coronary artery disease, dementia and atrial fibrillation.

Chronic obstructive pulmonary disease (COPD), kidney disease, cancer and congestive heart failure were the other major co-morbid conditions suffered by the people who died of COVID-19.

Experts, however, warn asthmatics against feeling complacent with these initial findings. Viral infections are a well-known cause of asthma exacerbations. Also, the flu and milder coronaviruses aggravate asthma attacks.